nodes	percent_of_prediction	percent_of_DWPC	metapath
Clindamycin—CYP3A4—bone cancer	0.89	1	CbGaD
Clindamycin—Bacterial infection—Methotrexate—bone cancer	0.00113	0.0103	CcSEcCtD
Clindamycin—Haematochezia—Doxorubicin—bone cancer	0.00113	0.0102	CcSEcCtD
Clindamycin—Tenderness—Cisplatin—bone cancer	0.00109	0.00991	CcSEcCtD
Clindamycin—Fungal skin infection—Doxorubicin—bone cancer	0.00109	0.00984	CcSEcCtD
Clindamycin—Ulcer—Cisplatin—bone cancer	0.00101	0.00915	CcSEcCtD
Clindamycin—Pain—Carboplatin—bone cancer	0.000993	0.009	CcSEcCtD
Clindamycin—Azotaemia—Methotrexate—bone cancer	0.000983	0.00891	CcSEcCtD
Clindamycin—Vaginal moniliasis—Epirubicin—bone cancer	0.000971	0.0088	CcSEcCtD
Clindamycin—Vulvovaginal candidiasis—Epirubicin—bone cancer	0.000932	0.00845	CcSEcCtD
Clindamycin—Body temperature increased—Carboplatin—bone cancer	0.000918	0.00832	CcSEcCtD
Clindamycin—Skin exfoliation—Cisplatin—bone cancer	0.000911	0.00826	CcSEcCtD
Clindamycin—Vaginal moniliasis—Doxorubicin—bone cancer	0.000899	0.00814	CcSEcCtD
Clindamycin—Vulvovaginal mycotic infection—Epirubicin—bone cancer	0.000897	0.00812	CcSEcCtD
Clindamycin—Local reaction—Epirubicin—bone cancer	0.000885	0.00802	CcSEcCtD
Clindamycin—Vesiculobullous rash—Epirubicin—bone cancer	0.000874	0.00792	CcSEcCtD
Clindamycin—Vulvovaginal candidiasis—Doxorubicin—bone cancer	0.000863	0.00782	CcSEcCtD
Clindamycin—Vaginal discharge—Methotrexate—bone cancer	0.000861	0.0078	CcSEcCtD
Clindamycin—Folliculitis—Methotrexate—bone cancer	0.000833	0.00755	CcSEcCtD
Clindamycin—Vulvovaginal mycotic infection—Doxorubicin—bone cancer	0.00083	0.00752	CcSEcCtD
Clindamycin—Local reaction—Doxorubicin—bone cancer	0.000819	0.00742	CcSEcCtD
Clindamycin—Vesiculobullous rash—Doxorubicin—bone cancer	0.000809	0.00733	CcSEcCtD
Clindamycin—Pelvic pain—Epirubicin—bone cancer	0.000806	0.0073	CcSEcCtD
Clindamycin—Vaginal discharge—Epirubicin—bone cancer	0.000806	0.0073	CcSEcCtD
Clindamycin—Folliculitis—Epirubicin—bone cancer	0.00078	0.00707	CcSEcCtD
Clindamycin—Pelvic pain—Doxorubicin—bone cancer	0.000745	0.00676	CcSEcCtD
Clindamycin—Vaginal discharge—Doxorubicin—bone cancer	0.000745	0.00676	CcSEcCtD
Clindamycin—Redness—Epirubicin—bone cancer	0.000726	0.00658	CcSEcCtD
Clindamycin—Folliculitis—Doxorubicin—bone cancer	0.000722	0.00654	CcSEcCtD
Clindamycin—Seborrhoeic dermatitis—Epirubicin—bone cancer	0.000719	0.00652	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Cisplatin—bone cancer	0.000716	0.00649	CcSEcCtD
Clindamycin—Fungal infection—Methotrexate—bone cancer	0.000678	0.00615	CcSEcCtD
Clindamycin—Redness—Doxorubicin—bone cancer	0.000672	0.00609	CcSEcCtD
Clindamycin—Seborrhoeic dermatitis—Doxorubicin—bone cancer	0.000665	0.00603	CcSEcCtD
Clindamycin—Vaginal haemorrhage—Epirubicin—bone cancer	0.000662	0.006	CcSEcCtD
Clindamycin—Abscess—Methotrexate—bone cancer	0.000662	0.006	CcSEcCtD
Clindamycin—Rash erythematous—Epirubicin—bone cancer	0.00064	0.0058	CcSEcCtD
Clindamycin—Fungal infection—Epirubicin—bone cancer	0.000635	0.00575	CcSEcCtD
Clindamycin—Cramp muscle—Cisplatin—bone cancer	0.000624	0.00565	CcSEcCtD
Clindamycin—Abscess—Epirubicin—bone cancer	0.000619	0.00561	CcSEcCtD
Clindamycin—Rash pustular—Epirubicin—bone cancer	0.000615	0.00557	CcSEcCtD
Clindamycin—Vaginal haemorrhage—Doxorubicin—bone cancer	0.000613	0.00555	CcSEcCtD
Clindamycin—Stinging—Epirubicin—bone cancer	0.000605	0.00548	CcSEcCtD
Clindamycin—Proteinuria—Methotrexate—bone cancer	0.000596	0.0054	CcSEcCtD
Clindamycin—Rash erythematous—Doxorubicin—bone cancer	0.000592	0.00537	CcSEcCtD
Clindamycin—Protein urine present—Methotrexate—bone cancer	0.000588	0.00533	CcSEcCtD
Clindamycin—Fungal infection—Doxorubicin—bone cancer	0.000587	0.00532	CcSEcCtD
Clindamycin—Abdominal discomfort—Cisplatin—bone cancer	0.000574	0.0052	CcSEcCtD
Clindamycin—Abscess—Doxorubicin—bone cancer	0.000573	0.00519	CcSEcCtD
Clindamycin—Rash pustular—Doxorubicin—bone cancer	0.000569	0.00515	CcSEcCtD
Clindamycin—Oliguria—Methotrexate—bone cancer	0.000568	0.00515	CcSEcCtD
Clindamycin—Stinging—Doxorubicin—bone cancer	0.00056	0.00507	CcSEcCtD
Clindamycin—Ulcer—Methotrexate—bone cancer	0.000554	0.00502	CcSEcCtD
Clindamycin—Inflammation—Methotrexate—bone cancer	0.00054	0.00489	CcSEcCtD
Clindamycin—Oliguria—Epirubicin—bone cancer	0.000532	0.00482	CcSEcCtD
Clindamycin—Vaginal inflammation—Methotrexate—bone cancer	0.000524	0.00475	CcSEcCtD
Clindamycin—Ulcer—Epirubicin—bone cancer	0.000518	0.0047	CcSEcCtD
Clindamycin—Inflammation—Epirubicin—bone cancer	0.000505	0.00458	CcSEcCtD
Clindamycin—Skin exfoliation—Methotrexate—bone cancer	0.0005	0.00453	CcSEcCtD
Clindamycin—Vaginal infection—Methotrexate—bone cancer	0.000494	0.00448	CcSEcCtD
Clindamycin—Oliguria—Doxorubicin—bone cancer	0.000492	0.00446	CcSEcCtD
Clindamycin—Vaginal inflammation—Epirubicin—bone cancer	0.00049	0.00444	CcSEcCtD
Clindamycin—Dermatitis contact—Epirubicin—bone cancer	0.000484	0.00439	CcSEcCtD
Clindamycin—Ulcer—Doxorubicin—bone cancer	0.000479	0.00435	CcSEcCtD
Clindamycin—Colitis—Epirubicin—bone cancer	0.000471	0.00426	CcSEcCtD
Clindamycin—Skin exfoliation—Epirubicin—bone cancer	0.000468	0.00424	CcSEcCtD
Clindamycin—Candida infection—Epirubicin—bone cancer	0.000468	0.00424	CcSEcCtD
Clindamycin—Inflammation—Doxorubicin—bone cancer	0.000468	0.00424	CcSEcCtD
Clindamycin—Vaginal infection—Epirubicin—bone cancer	0.000463	0.00419	CcSEcCtD
Clindamycin—Vaginal inflammation—Doxorubicin—bone cancer	0.000454	0.00411	CcSEcCtD
Clindamycin—Dermatitis contact—Doxorubicin—bone cancer	0.000448	0.00406	CcSEcCtD
Clindamycin—Oesophagitis—Epirubicin—bone cancer	0.000448	0.00406	CcSEcCtD
Clindamycin—Rash maculo-papular—Epirubicin—bone cancer	0.000445	0.00404	CcSEcCtD
Clindamycin—Flushing—Cisplatin—bone cancer	0.000445	0.00403	CcSEcCtD
Clindamycin—Thrombophlebitis—Methotrexate—bone cancer	0.000439	0.00398	CcSEcCtD
Clindamycin—Colitis—Doxorubicin—bone cancer	0.000435	0.00395	CcSEcCtD
Clindamycin—Candida infection—Doxorubicin—bone cancer	0.000433	0.00392	CcSEcCtD
Clindamycin—Skin exfoliation—Doxorubicin—bone cancer	0.000433	0.00392	CcSEcCtD
Clindamycin—Vaginal infection—Doxorubicin—bone cancer	0.000428	0.00388	CcSEcCtD
Clindamycin—Erythema—Cisplatin—bone cancer	0.000417	0.00378	CcSEcCtD
Clindamycin—Oesophagitis—Doxorubicin—bone cancer	0.000414	0.00376	CcSEcCtD
Clindamycin—Rash maculo-papular—Doxorubicin—bone cancer	0.000412	0.00374	CcSEcCtD
Clindamycin—Flatulence—Cisplatin—bone cancer	0.000411	0.00373	CcSEcCtD
Clindamycin—Thrombophlebitis—Epirubicin—bone cancer	0.000411	0.00372	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Methotrexate—bone cancer	0.000403	0.00365	CcSEcCtD
Clindamycin—Muscle spasms—Cisplatin—bone cancer	0.000401	0.00364	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Methotrexate—bone cancer	0.000393	0.00356	CcSEcCtD
Clindamycin—Anaemia—Cisplatin—bone cancer	0.000386	0.00349	CcSEcCtD
Clindamycin—Thrombophlebitis—Doxorubicin—bone cancer	0.00038	0.00345	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Epirubicin—bone cancer	0.000377	0.00342	CcSEcCtD
Clindamycin—Leukopenia—Cisplatin—bone cancer	0.000373	0.00338	CcSEcCtD
Clindamycin—Dermatitis bullous—Epirubicin—bone cancer	0.000372	0.00337	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Epirubicin—bone cancer	0.000368	0.00333	CcSEcCtD
Clindamycin—Discomfort—Cisplatin—bone cancer	0.000351	0.00318	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000349	0.00316	CcSEcCtD
Clindamycin—Dermatitis bullous—Doxorubicin—bone cancer	0.000344	0.00312	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000342	0.0031	CcSEcCtD
Clindamycin—Anaphylactic shock—Cisplatin—bone cancer	0.000341	0.00309	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Doxorubicin—bone cancer	0.00034	0.00308	CcSEcCtD
Clindamycin—Cardiac arrest—Epirubicin—bone cancer	0.000338	0.00307	CcSEcCtD
Clindamycin—Thrombocytopenia—Cisplatin—bone cancer	0.000333	0.00302	CcSEcCtD
Clindamycin—Dry skin—Epirubicin—bone cancer	0.000326	0.00296	CcSEcCtD
Clindamycin—Eosinophilia—Methotrexate—bone cancer	0.000325	0.00295	CcSEcCtD
Clindamycin—Abdominal pain upper—Epirubicin—bone cancer	0.000325	0.00295	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00032	0.0029	CcSEcCtD
Clindamycin—Hypotension—Cisplatin—bone cancer	0.000318	0.00288	CcSEcCtD
Clindamycin—Abdominal discomfort—Methotrexate—bone cancer	0.000315	0.00285	CcSEcCtD
Clindamycin—Cardiac arrest—Doxorubicin—bone cancer	0.000313	0.00284	CcSEcCtD
Clindamycin—Abdominal distension—Epirubicin—bone cancer	0.00031	0.00281	CcSEcCtD
Clindamycin—Dysuria—Methotrexate—bone cancer	0.000307	0.00278	CcSEcCtD
Clindamycin—Neutropenia—Methotrexate—bone cancer	0.000307	0.00278	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Methotrexate—bone cancer	0.000305	0.00277	CcSEcCtD
Clindamycin—Eosinophilia—Epirubicin—bone cancer	0.000304	0.00276	CcSEcCtD
Clindamycin—Dyspnoea—Cisplatin—bone cancer	0.000304	0.00275	CcSEcCtD
Clindamycin—Dry skin—Doxorubicin—bone cancer	0.000302	0.00273	CcSEcCtD
Clindamycin—Abdominal pain upper—Doxorubicin—bone cancer	0.000301	0.00272	CcSEcCtD
Clindamycin—Photosensitivity reaction—Methotrexate—bone cancer	0.0003	0.00272	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000296	0.00269	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Cisplatin—bone cancer	0.000294	0.00266	CcSEcCtD
Clindamycin—Pain—Cisplatin—bone cancer	0.000291	0.00264	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00029	0.00263	CcSEcCtD
Clindamycin—Neutropenia—Epirubicin—bone cancer	0.000288	0.00261	CcSEcCtD
Clindamycin—Dysuria—Epirubicin—bone cancer	0.000288	0.00261	CcSEcCtD
Clindamycin—Abdominal distension—Doxorubicin—bone cancer	0.000286	0.0026	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Epirubicin—bone cancer	0.000286	0.00259	CcSEcCtD
Clindamycin—Eosinophilia—Doxorubicin—bone cancer	0.000282	0.00255	CcSEcCtD
Clindamycin—Photosensitivity reaction—Epirubicin—bone cancer	0.000281	0.00254	CcSEcCtD
Clindamycin—Epistaxis—Methotrexate—bone cancer	0.000276	0.0025	CcSEcCtD
Clindamycin—Agranulocytosis—Methotrexate—bone cancer	0.000273	0.00248	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000272	0.00246	CcSEcCtD
Clindamycin—Body temperature increased—Cisplatin—bone cancer	0.000269	0.00244	CcSEcCtD
Clindamycin—Jaundice—Epirubicin—bone cancer	0.000267	0.00242	CcSEcCtD
Clindamycin—Urinary tract infection—Epirubicin—bone cancer	0.000267	0.00242	CcSEcCtD
Clindamycin—Dysuria—Doxorubicin—bone cancer	0.000266	0.00241	CcSEcCtD
Clindamycin—Neutropenia—Doxorubicin—bone cancer	0.000266	0.00241	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000264	0.0024	CcSEcCtD
Clindamycin—Photosensitivity reaction—Doxorubicin—bone cancer	0.00026	0.00235	CcSEcCtD
Clindamycin—Epistaxis—Epirubicin—bone cancer	0.000259	0.00234	CcSEcCtD
Clindamycin—Agranulocytosis—Epirubicin—bone cancer	0.000256	0.00232	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000252	0.00228	CcSEcCtD
Clindamycin—Hypersensitivity—Cisplatin—bone cancer	0.000251	0.00227	CcSEcCtD
Clindamycin—Erythema multiforme—Methotrexate—bone cancer	0.000249	0.00225	CcSEcCtD
Clindamycin—Jaundice—Doxorubicin—bone cancer	0.000247	0.00224	CcSEcCtD
Clindamycin—Urinary tract infection—Doxorubicin—bone cancer	0.000247	0.00223	CcSEcCtD
Clindamycin—Asthenia—Cisplatin—bone cancer	0.000244	0.00221	CcSEcCtD
Clindamycin—Epistaxis—Doxorubicin—bone cancer	0.000239	0.00217	CcSEcCtD
Clindamycin—Agranulocytosis—Doxorubicin—bone cancer	0.000237	0.00215	CcSEcCtD
Clindamycin—Diarrhoea—Cisplatin—bone cancer	0.000233	0.00211	CcSEcCtD
Clindamycin—Erythema multiforme—Epirubicin—bone cancer	0.000233	0.00211	CcSEcCtD
Clindamycin—Erythema—Methotrexate—bone cancer	0.000229	0.00207	CcSEcCtD
Clindamycin—Flushing—Epirubicin—bone cancer	0.000228	0.00207	CcSEcCtD
Clindamycin—Dysgeusia—Methotrexate—bone cancer	0.000224	0.00203	CcSEcCtD
Clindamycin—Back pain—Methotrexate—bone cancer	0.000221	0.00201	CcSEcCtD
Clindamycin—Vomiting—Cisplatin—bone cancer	0.000217	0.00196	CcSEcCtD
Clindamycin—Erythema multiforme—Doxorubicin—bone cancer	0.000215	0.00195	CcSEcCtD
Clindamycin—Rash—Cisplatin—bone cancer	0.000215	0.00195	CcSEcCtD
Clindamycin—Dermatitis—Cisplatin—bone cancer	0.000215	0.00194	CcSEcCtD
Clindamycin—Erythema—Epirubicin—bone cancer	0.000214	0.00194	CcSEcCtD
Clindamycin—Anaemia—Methotrexate—bone cancer	0.000212	0.00192	CcSEcCtD
Clindamycin—Flushing—Doxorubicin—bone cancer	0.000211	0.00192	CcSEcCtD
Clindamycin—Flatulence—Epirubicin—bone cancer	0.000211	0.00191	CcSEcCtD
Clindamycin—Dysgeusia—Epirubicin—bone cancer	0.00021	0.0019	CcSEcCtD
Clindamycin—Back pain—Epirubicin—bone cancer	0.000207	0.00188	CcSEcCtD
Clindamycin—Muscle spasms—Epirubicin—bone cancer	0.000206	0.00187	CcSEcCtD
Clindamycin—Vertigo—Methotrexate—bone cancer	0.000206	0.00186	CcSEcCtD
Clindamycin—Leukopenia—Methotrexate—bone cancer	0.000205	0.00186	CcSEcCtD
Clindamycin—Nausea—Cisplatin—bone cancer	0.000202	0.00183	CcSEcCtD
Clindamycin—Erythema—Doxorubicin—bone cancer	0.000198	0.0018	CcSEcCtD
Clindamycin—Anaemia—Epirubicin—bone cancer	0.000198	0.00179	CcSEcCtD
Clindamycin—Flatulence—Doxorubicin—bone cancer	0.000195	0.00177	CcSEcCtD
Clindamycin—Dysgeusia—Doxorubicin—bone cancer	0.000194	0.00176	CcSEcCtD
Clindamycin—Discomfort—Methotrexate—bone cancer	0.000193	0.00175	CcSEcCtD
Clindamycin—Vertigo—Epirubicin—bone cancer	0.000193	0.00174	CcSEcCtD
Clindamycin—Leukopenia—Epirubicin—bone cancer	0.000192	0.00174	CcSEcCtD
Clindamycin—Back pain—Doxorubicin—bone cancer	0.000192	0.00174	CcSEcCtD
Clindamycin—Muscle spasms—Doxorubicin—bone cancer	0.000191	0.00173	CcSEcCtD
Clindamycin—Anaphylactic shock—Methotrexate—bone cancer	0.000187	0.00169	CcSEcCtD
Clindamycin—Hypertension—Epirubicin—bone cancer	0.000185	0.00168	CcSEcCtD
Clindamycin—Anaemia—Doxorubicin—bone cancer	0.000183	0.00166	CcSEcCtD
Clindamycin—Thrombocytopenia—Methotrexate—bone cancer	0.000183	0.00166	CcSEcCtD
Clindamycin—Discomfort—Epirubicin—bone cancer	0.00018	0.00163	CcSEcCtD
Clindamycin—Vertigo—Doxorubicin—bone cancer	0.000178	0.00161	CcSEcCtD
Clindamycin—Leukopenia—Doxorubicin—bone cancer	0.000177	0.00161	CcSEcCtD
Clindamycin—Anaphylactic shock—Epirubicin—bone cancer	0.000175	0.00158	CcSEcCtD
Clindamycin—Hypotension—Methotrexate—bone cancer	0.000175	0.00158	CcSEcCtD
Clindamycin—Thrombocytopenia—Epirubicin—bone cancer	0.000171	0.00155	CcSEcCtD
Clindamycin—Hypertension—Doxorubicin—bone cancer	0.000171	0.00155	CcSEcCtD
Clindamycin—Discomfort—Doxorubicin—bone cancer	0.000167	0.00151	CcSEcCtD
Clindamycin—Dyspnoea—Methotrexate—bone cancer	0.000167	0.00151	CcSEcCtD
Clindamycin—Dyspepsia—Methotrexate—bone cancer	0.000164	0.00149	CcSEcCtD
Clindamycin—Hypotension—Epirubicin—bone cancer	0.000163	0.00148	CcSEcCtD
Clindamycin—Anaphylactic shock—Doxorubicin—bone cancer	0.000162	0.00147	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Methotrexate—bone cancer	0.000161	0.00146	CcSEcCtD
Clindamycin—Fatigue—Methotrexate—bone cancer	0.000161	0.00146	CcSEcCtD
Clindamycin—Pain—Methotrexate—bone cancer	0.00016	0.00145	CcSEcCtD
Clindamycin—Thrombocytopenia—Doxorubicin—bone cancer	0.000158	0.00144	CcSEcCtD
Clindamycin—Dyspnoea—Epirubicin—bone cancer	0.000156	0.00141	CcSEcCtD
Clindamycin—Dyspepsia—Epirubicin—bone cancer	0.000154	0.0014	CcSEcCtD
Clindamycin—Gastrointestinal pain—Methotrexate—bone cancer	0.000153	0.00138	CcSEcCtD
Clindamycin—Hypotension—Doxorubicin—bone cancer	0.000151	0.00137	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Epirubicin—bone cancer	0.000151	0.00137	CcSEcCtD
Clindamycin—Fatigue—Epirubicin—bone cancer	0.000151	0.00137	CcSEcCtD
Clindamycin—Pain—Epirubicin—bone cancer	0.00015	0.00136	CcSEcCtD
Clindamycin—Constipation—Epirubicin—bone cancer	0.00015	0.00136	CcSEcCtD
Clindamycin—Urticaria—Methotrexate—bone cancer	0.000148	0.00135	CcSEcCtD
Clindamycin—Abdominal pain—Methotrexate—bone cancer	0.000148	0.00134	CcSEcCtD
Clindamycin—Body temperature increased—Methotrexate—bone cancer	0.000148	0.00134	CcSEcCtD
Clindamycin—Dyspnoea—Doxorubicin—bone cancer	0.000144	0.00131	CcSEcCtD
Clindamycin—Gastrointestinal pain—Epirubicin—bone cancer	0.000143	0.0013	CcSEcCtD
Clindamycin—Dyspepsia—Doxorubicin—bone cancer	0.000142	0.00129	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00014	0.00127	CcSEcCtD
Clindamycin—Fatigue—Doxorubicin—bone cancer	0.000139	0.00126	CcSEcCtD
Clindamycin—Urticaria—Epirubicin—bone cancer	0.000139	0.00126	CcSEcCtD
Clindamycin—Constipation—Doxorubicin—bone cancer	0.000138	0.00125	CcSEcCtD
Clindamycin—Pain—Doxorubicin—bone cancer	0.000138	0.00125	CcSEcCtD
Clindamycin—Body temperature increased—Epirubicin—bone cancer	0.000138	0.00125	CcSEcCtD
Clindamycin—Abdominal pain—Epirubicin—bone cancer	0.000138	0.00125	CcSEcCtD
Clindamycin—Hypersensitivity—Methotrexate—bone cancer	0.000138	0.00125	CcSEcCtD
Clindamycin—Asthenia—Methotrexate—bone cancer	0.000134	0.00122	CcSEcCtD
Clindamycin—Gastrointestinal pain—Doxorubicin—bone cancer	0.000132	0.0012	CcSEcCtD
Clindamycin—Pruritus—Methotrexate—bone cancer	0.000132	0.0012	CcSEcCtD
Clindamycin—Hypersensitivity—Epirubicin—bone cancer	0.000129	0.00117	CcSEcCtD
Clindamycin—Urticaria—Doxorubicin—bone cancer	0.000129	0.00116	CcSEcCtD
Clindamycin—Abdominal pain—Doxorubicin—bone cancer	0.000128	0.00116	CcSEcCtD
Clindamycin—Body temperature increased—Doxorubicin—bone cancer	0.000128	0.00116	CcSEcCtD
Clindamycin—Diarrhoea—Methotrexate—bone cancer	0.000128	0.00116	CcSEcCtD
Clindamycin—Asthenia—Epirubicin—bone cancer	0.000125	0.00114	CcSEcCtD
Clindamycin—Pruritus—Epirubicin—bone cancer	0.000124	0.00112	CcSEcCtD
Clindamycin—Dizziness—Methotrexate—bone cancer	0.000124	0.00112	CcSEcCtD
Clindamycin—Diarrhoea—Epirubicin—bone cancer	0.00012	0.00108	CcSEcCtD
Clindamycin—Hypersensitivity—Doxorubicin—bone cancer	0.000119	0.00108	CcSEcCtD
Clindamycin—Vomiting—Methotrexate—bone cancer	0.000119	0.00108	CcSEcCtD
Clindamycin—Rash—Methotrexate—bone cancer	0.000118	0.00107	CcSEcCtD
Clindamycin—Dermatitis—Methotrexate—bone cancer	0.000118	0.00107	CcSEcCtD
Clindamycin—Headache—Methotrexate—bone cancer	0.000117	0.00106	CcSEcCtD
Clindamycin—Asthenia—Doxorubicin—bone cancer	0.000116	0.00105	CcSEcCtD
Clindamycin—Dizziness—Epirubicin—bone cancer	0.000116	0.00105	CcSEcCtD
Clindamycin—Pruritus—Doxorubicin—bone cancer	0.000114	0.00104	CcSEcCtD
Clindamycin—Vomiting—Epirubicin—bone cancer	0.000111	0.00101	CcSEcCtD
Clindamycin—Nausea—Methotrexate—bone cancer	0.000111	0.00101	CcSEcCtD
Clindamycin—Diarrhoea—Doxorubicin—bone cancer	0.000111	0.001	CcSEcCtD
Clindamycin—Rash—Epirubicin—bone cancer	0.00011	0.000999	CcSEcCtD
Clindamycin—Dermatitis—Epirubicin—bone cancer	0.00011	0.000998	CcSEcCtD
Clindamycin—Headache—Epirubicin—bone cancer	0.00011	0.000993	CcSEcCtD
Clindamycin—Dizziness—Doxorubicin—bone cancer	0.000107	0.00097	CcSEcCtD
Clindamycin—Nausea—Epirubicin—bone cancer	0.000104	0.000941	CcSEcCtD
Clindamycin—Vomiting—Doxorubicin—bone cancer	0.000103	0.000932	CcSEcCtD
Clindamycin—Rash—Doxorubicin—bone cancer	0.000102	0.000925	CcSEcCtD
Clindamycin—Dermatitis—Doxorubicin—bone cancer	0.000102	0.000924	CcSEcCtD
Clindamycin—Headache—Doxorubicin—bone cancer	0.000101	0.000919	CcSEcCtD
Clindamycin—Nausea—Doxorubicin—bone cancer	9.61e-05	0.000871	CcSEcCtD
